Ictal and lnterictal Endothelin-1 Levels in Migraine Patients

Vesile ÖZTÜRK, Fethi İDİMAN, Birsen ÇELİK, Murat SAYAN, Serkan ÖZAKBAŞ, Hakan ABACIOĞLU

Issue: 2002, Volume 8 - Issue 1
0 348

Cervicogenic Headache

Levent Ertuğrul İNAN, Harika MIHOĞLU

Issue: 1996, Volume 2 - Issue 1-2
0 257

Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.

Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA

Issue: 1995, Volume 1 - Issue 3
0 246

Anxiety and Depression in Chronic Headache

Deniz SELÇUKİ, Canan YÜCESAN, Nermin MUTLUER, Rana TANRIDAĞ, Gönül OZAN

Issue: 1995, Volume 1 - Issue 3
0 315

The wear-off phenomenon of repeated botulinum toxin injection for chronic migraine treatment: A retrospective study

Emir Ruşen, Gaye Hafez, Yeşim Tunç

DOI: 10.55697/tnd.2024.18

Issue: 2024, Volume 30 - Issue 1
1801 824

Could pulsed radiofrequency stimulation of the proximal greater occipital nerve be a treatment option for refractory chronic migraine patients?

Derya Yavuz Demiray, Ferhat Ege

DOI: 10.55697/tnd.2024.1

Issue: 2024, Volume 30 - Issue 4
754 513

Exploring the clinical significance of anemia in idiopathic intracranial hypertension

Nurhan Kaya Tutar, Mehmet Yerturk, Sami Omerhoca, Nilufer Kale

DOI: 10.55697/tnd.2024.208

Issue: 2024, Volume 30 - Issue 4
692 495

The comparative clinical effectiveness of withdrawal treatment with greater occipital nerve block at the C2 level with dexamethasone or bupivacaine in medication-overuse headache

Mustafa Karaoglan, Anıl Kılınç

DOI: 10.55697/tnd.2025.299

Issue: Online First
0 55